The use of network pharmacology and molecular dynamics studies, as demonstrated by research on Cassipourea metabolites, can help identify potential multi-target agents that modulate genes and enzymes implicated in melasma pathogenesis, such as COX-2, TYR, ESR2, and ESR1, and pathways like prolactin and estrogen signaling [29]. This evidence concerns the gene PRL and freckles.